10/2/2024Publication Announcement on the Inclusion of Marstacimab as Pilot Proj...

10/1/2024Asieris Pharma Reports Positive Phase III Results for Cervical HSIL Tr...

10/1/2024Kailera Secures $400M Series A Funding to Develop Obesity and Diabetes...

10/1/2024HUTCHMED Announces Japan Approval for FRUZAQLA (fruquintinib) Received...

10/1/2024NH Reports MAT H1/2024 Data on the Chinese Cough, Cold and Allergy Mar...

10/1/2024InventisBio Prevails in Trade Secret Misappropriation Lawsuit Filed by...

10/1/2024Alphamab and CSPC Enter a Licensing Deal on Anti-HER2 BsADC JSKN003 in...

10/1/2024Genentech to Acquire Regor Pharma’ Next-Generation CDK Inhibitor Port...

10/1/2024Akeso's Ebronucimab (PCSK9) Approved for Hypercholesterolemia in China

10/1/2024NMPA Conditionally Approves Qilu's QL1706 (Iparomlimab + Tuvonralimab)...

10/1/2024AstraZeneca's Seeks Chinese Approval of Antisense Therapy Eplontersen ...

10/1/2024Biotheus to Initiate Phase 3 Trial of BsAb PM8002 for SCLC

10/1/2024Regeneron and Sanofi Announced Chinese Approval of Dupixent as the Fir...

10/1/2024MediLink Registers Phase 3 Trial of Its B7H3 ADC YL201

10/1/2024Lepu Biopharma Files NDA for Lead Product EGFR ADC MRG003

10/1/2024Akeso's Cadonilimab Receives Second Indication Approval from NMPA

10/1/2024LEO Pharma Submits NDA for Enstilar for Adults with Plaque Psoriasis i...

10/1/2024Haleon Plans to Raise Stake in Chinese JV to 88%

10/1/2024AFT in China License Deal with Xizang Weixinkang Pharma for Maxigesic ...

10/1/2024China and US to Renew Health Cooperation Following Washington Talks

10/1/2024China's Pharmaceutical Antimonopoly Guidelines Pose New Challenges for...

9/27/2024Pharma Companies in Beijing Free Trade Zone to Benefit from Relaxed Da...

9/27/2024Daehwa Pharm's Liporaxel Gains Chinese Approval to Treat Gastric Cance...

9/27/2024China Rises as a Major Player in Oncology with ADCs Boom: GlobalData

9/27/2024Recent Executive Moves

9/27/2024TJ Biopharma Secures €213M Deal with Sanofi for Greater China Rights ...

9/27/2024Junshi Announces EC Approval of Toripalimab

9/27/2024Ribo and Pheiron Enter Strategic Deal for AI-assisted Drug Development...

9/27/2024Jixing Pharma Secures $2.75M in Series D+ Financing from Apeloa Hong K...

9/27/2024Innovent Submits Marketing Application for Antibody Drug IBI112 for Ps...

Page:48/775 Total number of articles:23222: [First][<<] [46] [47] [48] [49] [50] [>>] [End]